
DexCom (DXCM) Stock Forecast & Price Target
DexCom (DXCM) Analyst Ratings
Bulls say
DexCom is a leader in the diabetes device sector, with its CGM systems offering a more advanced and convenient alternative to traditional glucose monitoring methods. The company has a strong focus on innovation, with plans to integrate its technology with insulin pumps and develop adjacent software solutions. With strong financials and steady growth projections, DexCom is well-positioned for continued success in the diabetes market, making it a compelling investment opportunity.
Bears say
DexCom is a company in the continuous glucose monitoring space (CGM) that is facing intense competition, but still expects strong US growth and penetration into the Type 2 diabetes market in the future. While the company has seen improvements in margins and revenue growth, there are several risks that could potentially impact their performance, such as slower-than-expected adoption of their 15-day sensors or issues with their sales force. Their 2026 guidance was in line with expectations, but it remains to be seen if they can achieve the projected revenue growth and improve their profit margins.
This aggregate rating is based on analysts' research of DexCom and is not a guaranteed prediction by Public.com or investment advice.
DexCom (DXCM) Analyst Forecast & Price Prediction
Start investing in DexCom (DXCM)
Order type
Buy in
Order amount
Est. shares
0 shares